PHARMAIDS PHARMACEUTICALS LTD.
NSE : NABSE : 524572ISIN
CODE : INE117D01018Industry : Pharmaceuticals & DrugsHouse
: Private
BSE57.351.12 (+1.99 % )
PREV CLOSE (Rs.) 56.23
OPEN PRICE (Rs.) 57.35
BID PRICE (QTY) 57.35 (3258 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2513
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Financial ratio
| Particulars | Mar 2023 | Mar 2022 |
|---|---|---|
| Operational & Financial Ratios | ||
| Earnings Per Share (Rs) | -3.51 | 0.14 |
| CEPS(Rs) | -3.52 | 0.15 |
| DPS(Rs) | 0.00 | 0.00 |
| Book NAV/Share(Rs) | 10.26 | 8.44 |
| Tax Rate(%) | 23.74 | -3.48 |
| Margin Ratios | ||
| Core EBITDA Margin(%) | NA | 3.48 |
| EBIT Margin(%) | NA | 3.63 |
| Pre Tax Margin(%) | NA | 3.56 |
| PAT Margin (%) | NA | 3.68 |
| Cash Profit Margin (%) | NA | 3.92 |
| Performance Ratios | ||
| ROA(%) | -46.30 | 1.35 |
| ROE(%) | -49.28 | 1.67 |
| ROCE(%) | -63.87 | 1.65 |
| Asset Turnover(x) | 0.00 | 0.37 |
| Sales/Fixed Asset(x) | 0.00 | 7.75 |
| Working Capital/Sales(x) | 0.00 | 17.36 |
| Efficiency Ratios | ||
| Fixed Capital/Sales(x) | NA | 0.13 |
| Receivable days | NA | 124.04 |
| Inventory Days | NA | 82.25 |
| Payable days | 861.23 | 235.65 |
| Valuation Parameters | ||
| PER(x) | 0.00 | 88.51 |
| PCE(x) | -6.20 | 83.23 |
| Price/Book(x) | 2.13 | 1.48 |
| Yield(%) | 0.00 | 0.00 |
| EV/Net Sales(x) | NA | 3.16 |
| EV/Core EBITDA(x) | -3.44 | 81.73 |
| EV/EBIT(x) | -3.43 | 86.98 |
| EV/CE(x) | 1.55 | 1.16 |
| M Cap / Sales | NA | 3.26 |
| Growth Ratio | ||
| Net Sales Growth(%) | -100.00 | 0.00 |
| Core EBITDA Growth(%) | -6595.42 | 0.00 |
| EBIT Growth(%) | -7025.04 | 0.00 |
| PAT Growth(%) | -5305.67 | 0.00 |
| EPS Growth(%) | -2581.36 | 0.00 |
| Financial Stability Ratios | ||
| Total Debt/Equity(x) | 0.00 | 0.00 |
| Current Ratio(x) | 8.23 | 1.09 |
| Quick Ratio(x) | 8.23 | 0.73 |
| Interest Cover(x) | -2139.34 | 52.27 |
| Total Debt/Mcap(x) | 0.00 | 0.00 |
